We believe everything should start with a patient-first point of view. And it’s this mindset that shapes the way we deliver successful trials and help develop transformative drugs with speed. We work around the clock and around the world to prove that science of the highest quality can both solve global health issues and save individual lives. So when it comes to getting answers that drive drug development forward, consider us your source.
Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under the ticker symbol LH. Labcorp headquarters are located in Burlington, North Carolina.
Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under the ticker symbol LH. Labcorp headquarters are located in Burlington, North Carolina.
Location: Dominican Republic, Distrito Nacional, Santo Domingo
Phone: +1 888-268-2623
Mentions in press and media 22
| Date | Title | Description |
| 28.02.2023 | Approaches to Developing an AI-based Pharmacovigilance System – Automation is Changing the Way Pharma Manages Pharmacovigilance, Upcoming Webinar Hosted by Xtalks | The featured speakers will review innovative approaches regarding how pharmaceutical companies and CROs can collaborate and navigate this dynamic landscape. TORONTO (PRWEB) February 28, 2023 The field of pharmacovigilance is going through a... |
| 28.02.2023 | Approaches to Developing an AI-based Pharmacovigilance System – Automation is Changing the Way Pharma Manages Pharmacovigilance, Upcoming Webinar Hosted by Xtalks | In this free webinar, learn about how automation has changed the way patient safety operates. Attendees will learn what developments are on the forefront of AI-based pharmacovigilance systems. The featured speakers will discuss a model for ... |
| 23.02.2023 | Patient Centric Sampling: Bringing the Clinical Trials to the Patient, Upcoming Webinar Hosted by Xtalks | To fully realize the value of decentralization, remote patient centric sampling for laboratory pharmacokinetic, safety and biomarker measurements must be considered. TORONTO (PRWEB) February 23, 2023 Patient burden associated with clinical ... |
| 01.02.2023 | Breaking Down Barriers in Support of Patients with Rare Diseases, Upcoming Webinar Hosted by Xtalks | Success in this space requires collaboration across many stakeholders including families and patients, sites, investigators, labs, advocacy groups, regulators and the various service providers that support clinical trial delivery. Toronto, ... |
| 12.10.2022 | Time for Change in NASH: How Non-Invasive Biomarkers are Driving a Paradigm Shift in Clinical Trials and Clinical Care, Upcoming Webinar Hosted by Xtalks | Available data suggest that NITs can predict clinical outcomes and help accelerate clinical development and bring a safe and efficacious therapy to NASH patients with high unmet need. TORONTO (PRWEB) October 12, 2022 Diagnosing and assessin... |
| 14.09.2022 | Emerging Applications for Liquid Biopsy in Drug Development, Upcoming Webinar Hosted by Xtalks | Due to advances in next-generation sequencing for evaluation of the human genome, comprehensive analyses of circulating tumor DNA (ctDNA) through the liquid biopsy, represents a minimally invasive means to diagnose cancer. TORONTO, Ontario ... |
| 22.08.2022 | Current and Emerging Biomarkers to Advance Clinical Research in Parkinson’s Disease, Upcoming Webinar Hosted by Xtalks | Citing longitudinal research studies and recent clinical trials, the featured speakers will share the potential utility of fluid-based biomarkers and imaging biomarkers, discussing how each may help track drug efficacy and advance clinical ... |
| 18.08.2022 | Increasing Clinical Trial Diversity — Innovations to Overcome Barriers to Trial Participation, Upcoming Symposium Hosted by Xtalks | Join this symposium to discuss varied topics regarding patient advocacy, sites and sponsors and explore approaches and considerations to increase clinical trial diversity. TORONTO, Canada (PRWEB) August 18, 2022 Ensuring appropriate diverse... |
| 12.07.2022 | Health management platform Redi.Health partners with Labcorp | Redi will give LabCorp a new ability to connect with patients with communications channels and tools Redi.Health was founded with the goal of helping patients manage their health: the company builds tools specifically for patients with mult... |
| 12.07.2022 | Redi.Health Collaborates with Labcorp to Seamlessly Connect Patients and Providers | This collaboration is a significant steppingstone for the future of how patients will be able to manage their health and connect to pharmaceutical stakeholders. COLUMBUS, Ohio (PRWEB) July 12, 2022 Today, Redi.Health, provider of health man... |
Show more